{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:47:39Z","timestamp":1787500059289,"version":"build-2736575974"},"reference-count":68,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0492","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:08:42Z","timestamp":1769119722000},"page":"355-366","source":"Crossref","is-referenced-by-count":1,"title":["Consensus on the diagnosis of Cushing\u2019s disease: a collaborative statement from the Korean Endocrine Society and Japan Endocrine Society"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-8087","authenticated-orcid":false,"given":"Jeongmin","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Eunpyeong St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-653X","authenticated-orcid":false,"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Shin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-9902","authenticated-orcid":false,"given":"A Ram","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School, Gwangju 61469, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ouk","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul 02447, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Sang","family":"Baek","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Jun","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi 981-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Tahara","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School, Musashikosugi Hospital, Kanagawa 211-8233, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichi","family":"Oyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, Mita Hospital, Tokyo 108-8329, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai 980-8578, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Moriyama Memorial Hospital, Tokyo 134-0081, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 464-8601, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Joon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon 21936, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Sok","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Jib","family":"Yoo","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-8621","authenticated-orcid":false,"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Tokyo Women\u2019s Medical University School of Medicine, Tokyo 162-8666, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-9122","authenticated-orcid":false,"given":"Mi-kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Committee of Clinical Practice Guideline of Korean Endocrine Society","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Korean Neuroendocrine Study Group of Korean Endocrine Society","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Nieman LK (2022) Molecular derangements and the diagnosis of ACTH-dependent Cushing\u2019s syndrome. Endocr Rev 43: 852\u2013877.","DOI":"10.1210\/endrev\/bnab046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Park JS, Yun SJ, Lee JK, Park SY, Chin SO (2021) Descriptive epidemiology and survival analysis of prolactinomas and Cushing\u2019s disease in Korea. Endocrinol Metab (Seoul) 36: 688\u2013696.","DOI":"10.3803\/EnM.2021.1000"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Chin SO (2024) For the forthcoming winning shot in the battle against Cushing disease. Endocrinol Metab (Seoul) 39: 573\u2013575.","DOI":"10.3803\/EnM.2024.2075"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, et al. (2022) The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab 107: 2377\u20132388.","DOI":"10.1210\/clinem\/dgac265"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Valassi E, Santos A, Yaneva M, T\u00f3th M, Strasburger CJ, et al. (2011) The European Registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165: 383\u2013392.","DOI":"10.1530\/EJE-11-0272"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Sharma ST, Nieman LK, Feelders RA (2015) Comorbidities in Cushing\u2019s disease. Pituitary 18: 188\u2013194.","DOI":"10.1007\/s11102-015-0645-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330: 170\u2013181.","DOI":"10.1001\/jama.2023.11305"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, et al. (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93: 1526\u20131540.","DOI":"10.1210\/jc.2008-0125"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, et al. (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9: 847\u2013875.","DOI":"10.1016\/S2213-8587(21)00235-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hur KY, Kim JH, Kim BJ, Kim MS, Lee EJ, et al. (2015) Clinical Guidelines for the Diagnosis and Treatment of Cushing\u2019s Disease in Korea. Endocrinol Metab (Seoul) 30: 7\u201318.","DOI":"10.3803\/EnM.2015.30.1.7"},{"key":"11","unstructured":"11 (2023) Clinical practice guidelines for the diagnosis and management of hypothalamic-pituitary dysfunction, congenital arginine vasopressin resistance, and related disorders: 2023 edition by the Japan Endocrine Society. Nihon Naibunpi Gakkai Zasshi 99 (S. July): 1\u2013171 (In Japanese)."},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Motomura Y, Urai S, Bando H, Yamamoto M, Suzuki M, et al. (2024) Diagnostic dilemma in Cushing\u2019s syndrome: discrepancy between patient-reported and physician-assessed manifestations. Endocrine 86: 417\u2013427.","DOI":"10.1007\/s12020-024-03935-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Stratakis CA (2016) Skin manifestations of Cushing\u2019s syndrome. Rev Endocr Metab Disord 17: 283\u2013286.","DOI":"10.1007\/s11154-016-9399-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Lightman SL, Birnie MT, Conway-Campbell BL (2020) Dynamics of ACTH and cortisol secretion and implications for disease. Endocr Rev 41: bnaa002.","DOI":"10.1210\/endrev\/bnaa002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Wright K, van Rossum EFC, Zan E, Werner N, Harris A, et al. (2023) Emerging diagnostic methods and imaging modalities in cushing\u2019s syndrome. Front Endocrinol (Lausanne) 14: 1230447.","DOI":"10.3389\/fendo.2023.1230447"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing\u2019s disease. Best Pract Res Clin Endocrinol Metab 23: 607\u2013623.","DOI":"10.1016\/j.beem.2009.06.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hong AR, Kim JH, Hong ES, Kim IK, Park KS, et al. (2015) Limited diagnostic utility of plasma adrenocorticotropic hormone for differentiation between adrenal Cushing syndrome and Cushing disease. Endocrinol Metab (Seoul) 30: 297\u2013304.","DOI":"10.3803\/EnM.2015.30.3.297"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Hwang YC, Chung JH, Min YK, Lee MS, Lee MK, et al. (2009) Comparisons between macroadenomas and microadenomas in Cushing\u2019s disease: characteristics of hormone secretion and clinical outcomes. J Korean Med Sci 24: 46\u201351.","DOI":"10.3346\/jkms.2009.24.1.46"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Casals G, Hanzu FA (2020) Cortisol measurements in Cushing\u2019s syndrome: immunoassay or mass spectrometry? Ann Lab Med 40: 285\u2013296.","DOI":"10.3343\/alm.2020.40.4.285"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Clarke SA, Eng PC, Comninos AN, Lazarus K, Choudhury S, et al. (2024) Current challenges and future directions in the assessment of glucocorticoid status. Endocr Rev 45: 795\u2013817.","DOI":"10.1210\/endrev\/bnae016"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Guarnotta V, Amato MC, Pivonello R, Arnaldi G, Ciresi A, et al. (2017) The degree of urinary hypercortisolism is not correlated with the severity of cushing\u2019s syndrome. Endocrine 55: 564\u2013572.","DOI":"10.1007\/s12020-016-0914-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Loriaux DL (2017) Diagnosis and differential diagnosis of Cushing\u2019s syndrome. N Engl J Med 376: 1451\u20131459.","DOI":"10.1056\/NEJMra1505550"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Flowers KC, Shipman KE (2023) Pitfalls in the diagnosis and management of hypercortisolism (Cushing syndrome) in humans; a review of the laboratory medicine perspective. Diagnostics (Basel) 13: 1415.","DOI":"10.3390\/diagnostics13081415"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ahn SH, Kim JH, Baek SH, Kim H, Cho YY, et al. (2018) Characteristics of adrenal incidentalomas in a large, prospective computed tomography-based multicenter study: The COAR Study in Korea. Yonsei Med J 59: 501\u2013510.","DOI":"10.3349\/ymj.2018.59.4.501"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Shimatsu A, Biller BM, Fleseriu M, Pivonello R, Lee EJ, et al. (2024) Osilodrostat treatment in patients with Cushing\u2019s disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4). Endocr J 71: 1103\u20131123.","DOI":"10.1507\/endocrj.EJ24-0153"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, et al. (1987) Long term results of transsphenoidal adenomectomy in patients with Cushing\u2019s disease. Neurosurgery 21: 218\u2013222.","DOI":"10.1227\/00006123-198708000-00015"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kim JH, Shin CS, Paek SH, Jung HW, Kim SW, et al. (2012) Recurrence of Cushing\u2019s disease after primary transsphenoidal surgery in a university hospital in Korea. Endocr J 59: 881\u2013888.","DOI":"10.1507\/endocrj.EJ12-0109"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Parksook WW, Laichuthai N, Sunthornyothin S (2020) Clinical characteristics and treatment outcomes in endogenous Cushing\u2019s syndrome: a 15-year experience from Thailand. Case Rep Endocrinol 2020: 2946868.","DOI":"10.1155\/2020\/2946868"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Vining RF, McGinley RA, Maksvytis JJ, Ho KY (1983) Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem 20 (Pt 6): 329\u2013335.","DOI":"10.1177\/000456328302000601"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, et al. (2009) Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 42: 1205\u20131217.","DOI":"10.1016\/j.clinbiochem.2009.04.011"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Choi MH (2022) Clinical and technical aspects in free cortisol measurement. Endocrinol Metab (Seoul) 37: 599\u2013607.","DOI":"10.3803\/EnM.2022.1549"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Vining RF, McGinley RA (1987) The measurement of hormones in saliva: possibilities and pitfalls. J Steroid Biochem 27: 81\u201394.","DOI":"10.1016\/0022-4731(87)90297-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Carroll T, Raff H, Findling JW (2009) Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 15: 335\u2013342.","DOI":"10.4158\/EP09023OR"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Lin DC, Tsai PS, Lin YC (2019) Midnight salivary cortisol for the diagnosis of Cushing\u2019s syndrome in a Chinese population. Singapore Med J 60: 359\u2013363.","DOI":"10.11622\/smedj.2018154"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Sakihara S, Kageyama K, Oki Y, Doi M, Iwasaki Y, et al. (2010) Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing\u2019s syndrome. Endocr J 57: 331\u2013337.","DOI":"10.1507\/endocrj.K09E-340"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Yorke E, Atiase Y, Akpalu J, Sarfo-Kantanka O (2017) Screening for Cushing syndrome at the primary care level: what every general practitioner must know. Int J Endocrinol 2017: 1547358.","DOI":"10.1155\/2017\/1547358"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Martinerie L, Bouligand J, North MO, Bertherat J, Assi\u00e9 G, et al. (2024) Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) for the diagnosis of Cushing\u2019s syndrome: Genetics of Cushing\u2019s syndrome. Ann Endocrinol (Paris) 85: 284\u2013293.","DOI":"10.1016\/j.ando.2024.01.005"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Debono M, Bradburn M, Bull M, Harrison B, Ross RJ, et al. (2014) Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J Clin Endocrinol Metab 99: 4462\u20134470.","DOI":"10.1210\/jc.2014-3007"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Mansour N, Bruedgam D, Heinrich D, Dischinger U, Reisch N, et al. (2024) Mild autonomous cortisol secretion leads to reduced volumetric BMD at lumbar spine in patients with primary aldosteronism. Front Endocrinol (Lausanne) 15: 1521680.","DOI":"10.3389\/fendo.2024.1521680"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Hong AR, Kim JH, Park KS, Kim KY, Lee JH, et al. (2017) Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice. Eur J Endocrinol 177: 475\u2013483.","DOI":"10.1530\/EJE-17-0372"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Kageyama K, Oki Y, Sakihara S, Nigawara T, Terui K, et al. (2013) Evaluation of the diagnostic criteria for Cushing\u2019s disease in Japan. Endocr J 60: 127\u2013135.","DOI":"10.1507\/endocrj.EJ12-0299"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Oki Y, Hashimoto K, Hirata Y, Iwasaki Y, Nigawara T, et al. (2009) Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing\u2019s syndrome. Endocr J 56: 897\u2013904.","DOI":"10.1507\/endocrj.K09E-194"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Mondin A, Barbot M, Voltan G, Tizianel I, Vedolin CK, et al. (2023) Second-line tests in the differential diagnosis of neoplastic and non-neoplastic hypercortisolism: a systematic review and meta-analysis. J Endocrinol Invest 46: 1947\u20131959.","DOI":"10.1007\/s40618-023-02099-z"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Moro M, Putignano P, Losa M, Invitti C, Maraschini C, et al. (2000) The desmopressin test in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing states. J Clin Endocrinol Metab 85: 3569\u20133574.","DOI":"10.1210\/jcem.85.10.6862"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45 Shichi H, Fukuoka H, Kanzawa M, Yamamoto M, Yamamoto N, et al. (2022) Responsiveness to DDAVP in Cushing\u2019s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity. Pituitary 25: 496\u2013507.","DOI":"10.1007\/s11102-022-01220-4"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Giampietro RR, Cabral MVG, Pereira EG, Machado MC, Vilar L, et al. (2024) Accuracy of the 10 \u03bcg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 15: 1332120.","DOI":"10.3389\/fendo.2024.1332120"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Losa M, Mortini P, Dylgjeri S, Barzaghi R, Franzin A, et al. (2001) Desmopressin stimulation test before and after pituitary surgery in patients with Cushing\u2019s disease. Clin Endocrinol (Oxf) 55: 61\u201368.","DOI":"10.1046\/j.1365-2265.2001.01324.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Pinelli S, Barbot M, Scaroni C, Ceccato F (2021) Second-line tests in the diagnosis of adrenocorticotropic hormone-dependent hypercortisolism. Ann Lab Med 41: 521\u2013531.","DOI":"10.3343\/alm.2021.41.6.521"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Ceccato F, Di Dalmazi G (2023) Shortage of hCRH for the diagnosis of endogenous CS: the end of an era or the beginning of a new journey? J Endocrinol Invest 46: 2189\u20132191.","DOI":"10.1007\/s40618-023-02113-4"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Detomas M, Ritzel K, Nasi-Kordhishti I, Wolfsberger S, Quinkler M, et al. (2022) Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing\u2019s syndrome. Front Endocrinol (Lausanne) 13: 955945.","DOI":"10.3389\/fendo.2022.955945"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Savas M, Mehta S, Agrawal N, van Rossum EFC, Feelders RA (2022) Approach to the patient: diagnosis of Cushing syndrome. J Clin Endocrinol Metab 107: 3162\u20133174.","DOI":"10.1210\/clinem\/dgac492"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Nieman LK, Castinetti F, Newell-Price J, Valassi E, Drouin J, et al. (2025) Cushing syndrome. Nat Rev Dis Primers 11: 4.","DOI":"10.1038\/s41572-024-00588-w"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, et al. (2008) Accuracy of diagnostic tests for Cushing\u2019s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 93: 1553\u20131562.","DOI":"10.1210\/jc.2008-0139"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Bertherat J (2021) CRH-receptor molecular imaging reveals the intimacy of corticotroph adenomas. J Clin Endocrinol Metab 106: e1902\u2013e1904.","DOI":"10.1210\/clinem\/dgaa883"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Carton T, Mathieu E, Wolff F, Bouziotis J, Corvilain B, et al. (2021) Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives. Endocrinol Diabetes Metab 4: e00255.","DOI":"10.1002\/edm2.255"},{"key":"56","doi-asserted-by":"publisher","unstructured":"56 Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing\u2019s syndrome. Lancet 386: 913\u2013927.","DOI":"10.1016\/S0140-6736(14)61375-1"},{"key":"57","doi-asserted-by":"publisher","unstructured":"57 Barbot M, Trementino L, Zilio M, Ceccato F, Albiger N, et al. (2016) Second-line tests in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome. Pituitary 19: 488\u2013495.","DOI":"10.1007\/s11102-016-0729-y"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Aytug S, Laws ER, Jr., Vance ML (2012) Assessment of the utility of the high-dose dexamethasone suppression test in confirming the diagnosis of Cushing disease. Endocr Pract 18: 152\u2013157.","DOI":"10.4158\/EP11179.OR"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Lim JS, Lee SK, Kim SH, Lee EJ, Kim SH (2011) Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing\u2019s disease. Endocrine 40: 452\u2013461.","DOI":"10.1007\/s12020-011-9499-5"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Fukuhara N, Inoshita N, Yamaguchi-Okada M, Tatsushima K, Takeshita A, et al. (2019) Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing\u2019s disease. Endocr J 66: 259\u2013264.","DOI":"10.1507\/endocrj.EJ18-0458"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Grober Y, Grober H, Wintermark M, Jane JA, Oldfield EH (2018) Comparison of MRI techniques for detecting microadenomas in Cushing\u2019s disease. J Neurosurg 128: 1051\u20131057.","DOI":"10.3171\/2017.3.JNS163122"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Castle-Kirszbaum M, Amukotuwa S, Fuller P, Goldschlager T, Gonzalvo A, et al. (2023) MRI for Cushing disease: a systematic review. AJNR Am J Neuroradiol 44: 311\u2013316.","DOI":"10.3174\/ajnr.A7789"},{"key":"63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40644-023-00600-8","volume":"23","author":"K Kim","year":"2023","unstructured":"63 Kim K, Kim DK, Moon JH, Kim EH, Kim SH, et al. (2023) Dexamethasone suppression for (18)F-FDG PET\/CT to localize ACTH-secreting pituitary tumors. Cancer Imaging 23: 85.","journal-title":"Cancer Imaging","ISSN":"https:\/\/id.crossref.org\/issn\/1470-7330","issn-type":"print"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Valizadeh M, Rahmani F, Nikoohemmat M, Ramezani Ahmadi A, Hosseinpanah F, et al. (2024) Diagnostic accuracy of the desmopressin stimulation test in the comprehensive assessment of ACTH-dependent Cushing\u2019s syndrome: a comparative analysis with BIPSS and TSS. Endocr Res 49: 232\u2013242.","DOI":"10.1080\/07435800.2024.2381720"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Zampetti B, Grossrubatscher E, Dalino Ciaramella P, Boccardi E, Loli P (2016) Bilateral inferior petrosal sinus sampling. Endocr Connect 5: R12\u2013R25.","DOI":"10.1530\/EC-16-0029"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Valizadeh M, Abiri B, Hosseinpanah F, Grossman A (2024) Bilateral inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome: a reappraisal. J Intern Med 296: 2\u201323.","DOI":"10.1111\/joim.13789"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Mulligan GB, Faiman C, Gupta M, Kennedy L, Hatipoglu B, et al. (2012) Prolactin measurement during inferior petrosal sinus sampling improves the localization of pituitary adenomas in Cushing\u2019s disease. Clin Endocrinol (Oxf) 77: 268\u2013274.","DOI":"10.1111\/j.1365-2265.2012.04339.x"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Ishida A, Asakuno K, Shiramizu H, Yoshimoto H, Nakase K, et al. (2021) Revalidation of inferior petrosal sinus sampling: the latest results from a single-center experience. Endocr J 68: 1217\u20131223.","DOI":"10.1507\/endocrj.EJ21-0156"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/2\/73_EJ25-0492\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:25:10Z","timestamp":1770434710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/2\/73_EJ25-0492\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0492","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0492"}}